Aumgene Biosciences

Surat, India Founded: 2004 • Age: 22 yrs
Provider of contract research manufacturing of enzymes, probiotics agribiotech products

About Aumgene Biosciences

Aumgene Biosciences is a Healthcare company based in Surat (India) founded in 2004 by Anand Daga. Provider of contract research manufacturing of enzymes, probiotics agribiotech products. It operates in the Healthcare and Agriculture sectors. Aumgene Biosciences has raised $12.93 thousand across 1 funding round from investors including Paragbarter. The company has 56 employees. Aumgene Biosciences was last valued at $152.12 thousand in February 2008. Its Indian entity Aumgene Biosciences Private Limited reported revenue of β‚Ή46.06 Cr. Aumgene Biosciences offers products and services including Enzymes, Probiotics, Agribiotech Products, Contract Fermentation, and Contract Research. Its focus areas include Food and Agriculture Tech, Crop Tech, Farm Inputs and Biologicals.

Company details

Aumgene Biosciences was founded in 2004 in Surat, India, within the biotechnology sector. Contract research and manufacturing services for enzymes, probiotics, and agribiotech products are offered to pharmaceutical and biotechnology companies. Facilities for high-throughput screening of microbial strains, fermentation process development, and purification of enzymes and biologics are maintained. Toll manufacturing and related fermentation services are also provided across operations.

  • Headquarters Surat, India
  • Employees 56
  • Founders Anand Daga
  • Sectors
    Healthcare
    Agriculture
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website aumgene.com
  • Social LinkedIn
  • Legal Name Aumgene Biosciences Private Limited
  • Date of Incorporation 26 May, 2004
  • Jurisdiction Surat, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹46.06 Cr

    FY 2025 · +37% YoY

  • Net Profit
    ₹12.07 Cr

    FY 2025 · 26% margin

  • EBITDA
    ₹18.51 Cr

    FY 2025 · 40% margin

  • Total Equity Funding
    $12.93K (USD)

    in 1 rounds

  • Latest Funding Round
    $12.93K (USD), Seed

    Feb 2008

  • Employee Count
    56

Products & Services of Aumgene Biosciences

Aumgene Biosciences offers a comprehensive portfolio of products and services, including Enzymes, Probiotics, Agribiotech Products, Contract Fermentation, and Contract Research.

Enzymes
Biotech Products

Manufactured enzymes for industrial and biological applications.

Probiotics
Health Supplements

Probiotics for health, agriculture, and microbial enhancement.

Agribiotech Products
Agricultural Solutions

Biofertilizers to improve soil and crop productivity.

Contract Fermentation
Services

Fermentation services for external manufacturing needs.

Contract Research
Services

Research services for enzyme and biologic development.

Enzyme Testing
Services

Testing services to analyze enzyme properties and efficacy.

Spray Drying
Services

Drying processes for product formulation and preservation.

Funding Insights of Aumgene Biosciences

Aumgene Biosciences has successfully raised a total of $12.93K through 1 strategic funding round. The most recent funding activity was a Seed round of $12.93 thousand completed in February 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $12,928
  • Total Rounds 1
  • Last Round Seed β€” $12,928
  • First Round $12,928

    (Feb 2008)

  • Investors Count 1

All 1 funding rounds of Aumgene Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2008$12,928Seed$152,115–
Valuation history

Last known valuation $152,115 (Feb 2008). 1 investors in total: 1 institutional.

Investors in Aumgene Biosciences

Aumgene Biosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Paragbarter.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Premium access

Investor details for Aumgene Biosciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Aumgene Biosciences Private Limited (Aumgene Biosciences)

Aumgene Biosciences Private Limited is the primary company behind Aumgene Biosciences. The board of Aumgene Biosciences Private Limited currently have 2 directors; the longest-serving is Anand Kumar Daga, appointed in 2004. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Anand Kumar Daga
DIN 00581124
Director26 May 200422 yrs 5 moAumgene Biosciences Private Limited
Jaikumar Bajaj
DIN 01211299
Director26 May 200422 yrs 5 moAumgene Biosciences Private Limited

People of Aumgene Biosciences

1 people are tracked at Aumgene Biosciences (1 in leadership); the tracked headcount is 56.

NameRoleGroup
Founder & Managing DirectorLeadership
Premium access

Complete people profiles for Aumgene Biosciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Aumgene Biosciences

Figures of Aumgene Biosciences Private Limited, the primary company behind Aumgene Biosciences, for FY 2025. Revenue was ₹46.06 Cr (+37% year on year). Net profit was ₹12.07 Cr (26% margin). EBITDA was ₹18.51 Cr (40% margin). Revenue has grown at a compounded annual rate of +18% over three years and +12% over five years.

  • ₹46.06 CrRevenue · FY 2025 · +37% YoY
  • ₹12.07 CrNet profit · 26% margin
  • ₹18.51 CrEBITDA · 40% margin
  • ₹23.9 LakhPaid-up capital
  • 56Employees (provident fund records)
  • +18%Revenue CAGR, 3 years
  • +12%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Aumgene Biosciences Private Limited are on its company page.

Premium access

Detailed financial statements for Aumgene Biosciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Aumgene Biosciences

2 dated milestones of Aumgene Biosciences across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aumgene Biosciences is founded.
  2. Funding First funding round of $13K.

Web traffic of Aumgene Biosciences

The website of Aumgene Biosciences (aumgene.com) receives about 1.7K visits a month.

  • Monthly visits
    1.7K

    ▲ 78.2% vs previous month

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as Aumgene Biosciences (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Ayurvedic healthcare and nutritional products are provided by Kapiva.
2016Bengaluru, Karnataka, IndiaUSD 77.85 MUSD 55.41 M362
Nutritional supplements for multiple health ailments are developed.
2005Mumbai, Maharashtra, IndiaUSD 1.55 M
Nutritional food and health supplements are provided by OZiva.
2010Mumbai, Maharashtra, IndiaUSD 17.32 MUSD 56.21 M144
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Aumgene Biosciences

Premium access

Complete news archive for Aumgene Biosciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aumgene Biosciences

Aumgene Biosciences was founded in 2004 and raised its 1st funding round 4 years after it was founded.

Aumgene Biosciences is headquartered in Surat, India. It is registered at Surat, Gujarat, India.

Aumgene Biosciences is a funded company, having raised a total of $12.93K across 1 funding round to date. The company's 1st funding round was a Seed of $12.93K, raised on Feb 2008.

Aumgene Biosciences has 56 employees.

The primary company behind Aumgene Biosciences, Aumgene Biosciences Private Limited, reported revenue of β‚Ή46.06 Cr for FY 2025, up 37% year on year.

Aumgene Biosciences was founded in 2004 in Surat, India, within the biotechnology sector. Contract research and manufacturing services for enzymes, probiotics, and agribiotech products are offered to pharmaceutical and biotechnology companies. Facilities for high-throughput screening of microbial strains, fermentation process development, and purification of enzymes and biologics are maintained. Toll manufacturing and related fermentation services are also provided across operations.

Aumgene Biosciences offers Enzymes, Probiotics, Agribiotech Products, Contract Fermentation, and 3 more products and services.

Aumgene Biosciences has 1 investor. Key investors include Paragbarter.

The valuation of Aumgene Biosciences is $152.12K as of Feb 2008.

Aumgene Biosciences operates through Aumgene Biosciences Private Limited.

The legal entities of Aumgene Biosciences currently have 2 directors, including Anand Kumar Daga, Jaikumar Bajaj.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available